Seguir
María del Mar Noblejas López
María del Mar Noblejas López
Centro Regional de Investigaciones Biomédicas (UCLM)
Dirección de correo verificada de alu.uclm.es
Título
Citado por
Citado por
Año
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer
MM Noblejas-López, C Nieto-Jimenez, M Burgos, M Gómez-Juárez, ...
Journal of Experimental & Clinical Cancer Research 38, 1-9, 2019
822019
Controlled delivery of BET-PROTACs: in vitro evaluation of MZ1-loaded polymeric antibody conjugated nanoparticles in breast cancer
FJ Cimas, E Niza, A Juan, MM Noblejas-López, I Bravo, A Lara-Sanchez, ...
Pharmaceutics 12 (10), 986, 2020
472020
Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome
MDM Noblejas-López, C Nieto-Jiménez, S Morcillo Garcia, J Pérez-Peña, ...
Oncoimmunology 8 (10), e1629780, 2019
422019
Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer
E Niza, MM Noblejas-López, I Bravo, C Nieto-Jiménez, JA Castro-Osma, ...
Nanomaterials 9 (12), 1793, 2019
402019
Poly (cyclohexene phthalate) nanoparticles for controlled dasatinib delivery in breast cancer therapy
E Niza, C Nieto-Jiménez, MM Noblejas-López, I Bravo, JA Castro-Osma, ...
Nanomaterials 9 (9), 1208, 2019
252019
Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene
MM Noblejas-López, S Morcillo-Garcia, C Nieto-Jiménez, ...
PloS one 13 (11), e0207776, 2018
182018
Options to improve the action of PROTACs in cancer: development of controlled delivery nanoparticles
A Juan, MM Noblejas-López, M Arenas-Moreira, C Alonso-Moreno, ...
Frontiers in Cell and Developmental Biology, 3912, 2021
172021
Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer
C Nieto-Jimenez, EM Galan-Moya, V Corrales-Sanchez, ...
Cancer Letters 491, 50-59, 2020
172020
Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors
S Morcillo-Garcia, MM Noblejas-Lopez, C Nieto-Jimenez, J Perez-Peña, ...
PLoS One 14 (4), e0209134, 2019
172019
Mapping of genomic vulnerabilities in the post-translational ubiquitination, SUMOylation and neddylation machinery in breast cancer
J Fuentes-Antrás, AL Alcaraz-Sanabria, EC Morafraile, ...
Cancers 13 (4), 833, 2021
152021
Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer
V Corrales‐Sánchez, MM Noblejas‐López, C Nieto‐Jiménez, ...
Journal of Cellular and Molecular Medicine 24 (5), 3117-3127, 2020
122020
MZ1 co-operates with trastuzumab in HER2 positive breast cancer
MM Noblejas-López, C Nieto-Jiménez, EM Galán-Moya, D Tebar-García, ...
Journal of Experimental & Clinical Cancer Research 40, 1-12, 2021
102021
Antitumoral activity of a CDK9 PROTAC compound in HER2-positive breast cancer
MM Noblejas-López, L Gandullo-Sánchez, EM Galán-Moya, ...
International Journal of Molecular Sciences 23 (10), 5476, 2022
72022
Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1, CLNS1A, and ILF2 in Luminal Breast Cancer
MM Noblejas-López, I López-Cade, J Fuentes-Antrás, ...
Cancers 13 (16), 4118, 2021
62021
Enhanced antitumoral activity of encapsulated BET inhibitors when combined with PARP inhibitors for the treatment of triple-negative breast and ovarian cancers
A Juan, MM Noblejas-López, I Bravo, M Arenas-Moreira, ...
Cancers 14 (18), 4474, 2022
32022
Transcriptomic profiles of CD47 in breast tumors predict outcome and are associated with immune activation
MM Noblejas-López, M Baliu-Piqué, C Nieto-Jiménez, FJ Cimas, ...
International Journal of Molecular Sciences 22 (8), 3836, 2021
22021
TACkling Cancer by Targeting Selective Protein Degradation
MM Noblejas-López, D Tébar-García, R López-Rosa, A Alcaraz-Sanabria, ...
Pharmaceutics 15 (10), 2442, 2023
12023
T-reg transcriptomic signatures identify response to check-point inhibitors
MM Noblejas-López, E García-Gil, P Pérez-Segura, A Pandiella, B Győrffy, ...
Scientific Reports 14 (1), 10396, 2024
2024
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–18